As the team began thinking about its next stage of work, it was time to find a name for the venture. After considering a series
of different possibilities, they agreed on Acclarent. The decision to embed ENT (ear, nose, and throat) within the new company
name was intentional, as the group began to grow increasingly excited about the many opportunities to address unmet needs
in the field.
Their next efforts were focused on transforming the Balloon Sinuplasty™ concept into a product and building a business capable
of bringing that technology to market.
5.1 Intellectual property strategy
As described earlier, the team recognized intellectual property (IP) as an important ...